Philip Selby

Dr Philip Selby

Lecturer, Clinical Pharmacy Practice

School of Pharmacy and Biomedical Science

College of Health

Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.

Year Citation
2025 Wong, S., Selby, P. R., Ward, M. B., & Reuter, S. E. (2025). Exploring health care professionals' engagement with a precision dosing calculator and supporting clinical information: insights from an eye-tracking and usability study. Therapeutic Drug Monitoring, online(6), 1-10.
DOI
2025 Zhu, V. Z., Garg, P., Singh, N., Selby, P. R., Ierano, C., & Yong, M. K. (2025). Understanding antiviral intolerance in the management of cytomegalovirus; a scoping review.. Current opinion in infectious diseases.
DOI
2024 Selby, P. R., Heffernan, A. J., Yeung, D., Warner, M. S., Peake, S. L., Hahn, U., . . . Roberts, J. A. (2024). Population pharmacokinetics of posaconazole in allogeneic haematopoietic stem cell transplant patients. Journal of Antimicrobial Chemotherapy, 79(3), 567-577.
DOI Scopus3 WoS3 Europe PMC3
2024 Wong, S., Selby, P. R., & Reuter, S. E. (2024). Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients. Pharmacology Research & Perspectives, 12(4, article no. e1231), 1-10.
DOI Scopus1 WoS1
2023 Sharplin, K., Proudman, W., Chhetri, R., Tran, E. N. H., Choong, J., Kutyna, M., . . . Hiwase, D. (2023). A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data. Cancers, 15(16), 1-14.
DOI Scopus4 WoS4 Europe PMC3
2023 Cibich, M. A., Chhetri, R., Sharplin, K., Shanmuganathan, N., Singhal, D., Beligaswatte, A., . . . Hiwase, D. (2023). Comparable Survival Following Allogeneic Haematopoietic Stem Cell Transplant Utilising HLA-Matched Vs Alternative Donors: A Single-Centre Retrospective, Consecutive Cohort Analysis. Transplantation and Cellular Therapy, 29(2), S236-S237.
DOI
2023 Wong, S., Davis, A., Selby, P. R., Khoo, R., Gwilt, I., Stocker, S. L., . . . Reuter, S. E. (2023). Application of user-centered co-design principles to address barriers in therapeutic drug monitoring.. Therapeutic drug monitoring, 45(3), 368-375.
DOI Scopus4 WoS4 Europe PMC5
2023 Selby, P. R., Heffernan, A. J., Yeung, D., Warner, M. S., Peake, S. L., Hahn, U., . . . Roberts, J. A. (2023). Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant Patients. Antimicrobial Agents and Chemotherapy, 67(3), e0155022.
DOI Scopus3 WoS2 Europe PMC2
2022 Selby, P. R., Warner, M. S., Peake, S. L., Bardy, P., Hiwase, D., Singhal, D., . . . Shakib, S. (2022). Optimising antifungal prophylaxis in allogeneic stem cell transplantation - a cohort study of two different approaches. Transplant Infectious Disease, 24(6), 1-11.
DOI Scopus2 WoS2 Europe PMC2
2021 Selby, P. R., Shakib, S., Peake, S. L., Warner, M. S., Yeung, D., Hahn, U., & Roberts, J. A. (2021). A Systematic Review of the Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Ganciclovir/Valganciclovir in Allogeneic Haematopoietic Stem Cell Transplant Patients. Clinical Pharmacokinetics, 60(6), 727-739.
DOI Scopus14 WoS13 Europe PMC11
2019 Jones, T. E., Selby, P. R., Mellor, C. S., & Cheam, D. B. (2019). Ceftazidime stability and pyridine toxicity during continuous i.v. Infusion. American Journal of Health System Pharmacy, 76(4), 200-205.
DOI Scopus25 WoS26 Europe PMC17
2012 Selby, P. (2012). The rural hospital experience. Australian Journal of Pharmacy, 93(1107), 38.
2010 Cheh, R. M., Selby, P. R., Abarno, A. C., & Alderman, C. P. (2010). Outcomes of pharmacological management of violent behavioural disturbances in older hospital patients. Journal of pharmacy practice and research, 40(3), 184-186.
DOI Scopus1

Year Citation
2023 Selby, P. R., Sharplin, K. M., Osborn, M. P., & Yeung, D. T. (2023). Management of Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia. In Pathogenesis and Treatment of Leukemia (pp. 289-310). Springer Nature Singapore.
DOI

Year Citation
2024 Khanna, S., Haran, H., Wiseman, T., Hung, K., Sapio, A., Selby, P., . . . Hiwase, D. (2024). High Burden of Healthcare Utilization in Older Acute Myeloid Leukemia Patients Treated with First-Line Venetoclax-Based Therapies. In BLOOD Vol. 144 (pp. 4237-4238). FL, Orlando: ELSEVIER.
DOI
2023 Cibich, M. A., Wu, X., Sharplin, K., Pham, A., Shanmuganathan, N., Singhal, D., . . . Hiwase, D. (2023). Outcomes of ABO Incompatible Allogeneic Haematopoietic Stem Cell Transplant: A Single-Centre Retrospective Cohort Review. In Transplantation and Cellular Therapy Vol. 29 (pp. S141-S142). Elsevier BV.
DOI
2023 Cibich, M. A., Schultz, C., Sharplin, K., Chhetri, R., Selby, P., Shanmuganathan, N., . . . Hiwase, D. (2023). Incidence of Decreased Bone Mineral Density Post Allogeneic Haemopoietic Stem Cell Transplant: Single Institution Retrospective Analysis. In Transplantation and Cellular Therapy Vol. 29 (pp. S362-S363). Elsevier BV.
DOI
2022 Cibich, A., Chhetri, R., Sharplin, K. M., Shanmuganathan, N., Yeung, D. T., Singhal, D., . . . Hiwase, D. (2022). Comparable Survival Following Allogeneic Haematopoietic Stem Cell Transplant Utilising HLA-Matched Versus Alternative Donors: A Single-Centre Retrospective, Consecutive Cohort Analysis. In BLOOD Vol. 140 (pp. 4892-4893). LA, New Orleans: ELSEVIER.
DOI
2017 Chan, F., & Selby, P. (2017). Depression as a presenting symptom of relapse of CNS lymphoma-should we screen them all?. In JOURNAL OF THE NEUROLOGICAL SCIENCES Vol. 381 (pp. 386). Kyoto, JAPAN: ELSEVIER SCIENCE BV.
DOI

Courses I teach

  • PHAR 2025 Pharmacology and Pharmacotherapeutics for Midwives (2025)
  • PHAR 5057 Applied Clinical Pharmacy (2025)
  • PHAR 2025 Pharmacology and Pharmacotherapeutics for Midwives (2024)

Date Role Research Topic Program Degree Type Student Load Student Name
2024 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Mr Elias Constantinos Biris

Connect With Me

External Profiles

Other Links